EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

Flávia Nathiely Silveira Fachel iD, Angélica Salatino-Oliveira, Willian da Silva Carniel iD, Rafaela Zimmermann, Ursula Matte iD, Helder Ferreira Teixeira, Guilherme Baldo iD, Roselena Silvestri Schuh iD

Pharmaceutics · 10.09.2025 · 17 (9) · 1177

DOI: 10.3390/pharmaceutics17091177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 10.09.2025. Verfasst von Flávia Nathiely Silveira Fachel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre 90610-000, RS, Br…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Rio Grande do Sul Research Foundation, Coordination for the Improvement of Higher Education Personnel - Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nasal route represents a promising non-invasive technique for the direct delivery of nucleic acids to the central nervous system (CNS) disorders, effectively bypassing the blood–brain barrier. This route offers several advantages, including ease of administration, enhanced patient compliance, rapid therapeutic onset, and increased availability. Nonetheless, challenges such as mucociliary clearance, enzymatic degradation, and the low permeability of cell membranes to large molecules remain obstacles to the effectiveness of this approach. To address these limitations and achieve targeted nose-to-brain delivery with optimized therapeutic outcomes, various technological solutions have been explored, such as nanotechnology-based delivery systems and mucoadhesive formulations. These innovations aim to enhance the permeability of the nasal mucosa, extend the residence time of therapeutic agents in the nasal cavity, and improve overall treatment effectiveness. While the nasal gene delivery to the brain is still relatively new, it holds considerable potential for expanding treatment options for a range of CNS disorders. In this context, this review examines the anatomy and physiology of the nasal route, the mechanisms of biomolecule transport from nose to brain, the potential of gene delivery vectors, key preclinical advancements, and clinical perspectives for the nasal delivery of nucleic acids in CNS disorders.

Schlagwörter

Stichwörter der Autor:innen

CNS deliverybrain deliverynanotechnologynasal administrationnucleic acids

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre 90610-000, RS, Brazil.
  • Programa de Pós-Graduação em Genética e Biologia Molecular, Universidade Federal do Rio Grande do Sul, Porto Alegre 91501-970, RS, Brazil.
  • Laboratório Células, Tecidos e Genes, Serviço de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Porto Alegre 90410-000, RS, Brazil.

ORCID-Profile: Flávia Nathiely Silveira Fachel, Willian da Silva Carniel, Ursula Matte, Guilherme Baldo, Roselena Silvestri Schuh

Förderung

  • National Council for Scientific and Technological Development
  • Rio Grande do Sul Research Foundation
  • Coordination for the Improvement of Higher Education Personnel - Brazil
  • Coordination for the Improvement of Higher Education Personnel—Brazil

Zitieren

APA

Fachel, F. N. S., Salatino-Oliveira, A., Carniel, W. D. S., Zimmermann, R., Matte, U., Teixeira, H. F., Baldo, G., & Schuh, R. S. (2025). Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders. Pharmaceutics, 17(9), 1177. https://doi.org/10.3390/pharmaceutics17091177

Vancouver

Fachel FNS, Salatino-Oliveira A, Carniel WDS, Zimmermann R, Matte U, Teixeira HF, et al. Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders. Pharmaceutics. 2025;17(9):1177. doi:10.3390/pharmaceutics17091177

BibTeX
@article{Fachel2025,
  author = {Fachel, Flávia Nathiely Silveira and Salatino-Oliveira, Angélica and Carniel, Willian da Silva and Zimmermann, Rafaela and Matte, Ursula and Teixeira, Helder Ferreira and Baldo, Guilherme and Schuh, Roselena Silvestri},
  title = {Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1177},
  doi = {10.3390/pharmaceutics17091177}
}
Kostenlos starten →